Peter J Chockley (Peter Chockley)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Topics

Epstein Barr Virus

Top Venues

Nature biotechnology

Nature genetics

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Lindsey J Talbot, Ashley Chabot, Aaron B Ross, Alexandra Beckett, Phuong Nguyen, Andrew M Fleming, Peter J Chockley, Heather S Sheppard, Jian Wang, Stephen Gottschalk, Christopher DeRenzo
Redirecting B7-H3.CAR T cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Alex N Beckett, Peter J Chockley, Shondra M Pruett-Miller, Phuong Nguyen, Peter Vogel, Heather Sheppard, Giedre Krenciute, Stephen Gottschalk, Christopher DeRenzo
CD47 expression is critical for CAR T-cell survival in vivo. Journal for immunotherapy of cancer 11 (3) (2023)
Peter J Chockley, Jorge Ibañez-Vega, Giedre Krenciute, Lindsay J Talbot, Stephen Gottschalk
Synapse-tuned CARs enhance immune cell anti-tumor activity. Nature biotechnology (2023)
Constance Baer, Shunsuke Kimura, Mitra Shumsher Rana, Andrew B Kleist, Tim Flerlage, Thomas P Loughran, Peter J Chockley, Wencke Walter, Manja Meggendorfer, Thomas L Olson, HeeJin Cheon, Kristine C Olson, Aakrosh Ratan, Martha-Lena Mueller, James M Foran, Laura J Janke, Chunxu Qu, Shaina N Porter, Shondra M Pruett-Miller, Ravi C Kalathur, Claudia Haferlach, Wolfgang Kern, Elisabeth Paietta, Paul Glyndwr Thomas, M Madan Babu, Thomas P Loughran, Ilaria Iacobucci, Torsten Haferlach, Charles G Mullighan
CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk. Nature genetics 54 (5) (2022)
Ilaria Iacobucci, Reiji Fukano, Jake D Friske, Chunxu Qu, Laura J Janke, Yaqi Zhao, Pradyuamna Baviskar, Emily A Backhaus, Peter J Chockley, Aman Seth, A Douglas Laird, Anjali S Advani, Charles G Mullighan
G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL. Blood advances 6 (11) (2022)
Abdullah Freiwan, Jaquelyn T Zoine, Jeremy Chase Crawford, Abishek Vaidya, Stefan A Schattgen, Jacquelyn Myers, Sagar L Patil, Mahsa Khanlari, Hiroto Inaba, Jeffery M Klco, Charles G Mullighan, Giedre Krenciute, Peter J Chockley, Swati Naik, Deanna Langfitt, Maksim Mamonkin, Esther A Obeng, Paul Glyndwr Thomas, Stephen Gottschalk, Mireya Paulina Velasquez
Engineering Naturally Occurring CD7 Negative T Cells for the Immunotherapy of Hematological Malignancies. Blood (2022)
Peter J Chockley, Venkateshwar G Keshamouni
Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression. Journal of immunology (Baltimore, Md. : 1950) 197 (3) (2017)